Technological Monitoring Study Based on Invention Patents of Omeprazoleand Derivatives with Pharmaceutical Applications
Keywords:omeprazole, technological foresight, pharmaceutical patents
AbstractThe current study intends to present the relevance of omeprazole, esomeprazole, rabeprazole, pantoprazole and lansoprazole by means of the technological foresight study, through invention patent documents from Brazilian applicants as indicators of innovation. The European database of patents (Espacenet), Word Patent Index (DERWENT) and the Brazilian Patent Base of INPI were used, combining keywords and International Patent Classifications. The major applicants, countries of publication and claims categories were mapped. The 212 patent requests collected are mainly distributed in Chemistry, Pharmacy and Pharmacology areas. The results obtained revealed that the US was the main country with studies directed to this technological area (59 patent applications) and the major applicant was the company Astrazeneca AB. Therefore, we can understand that this is a promising technology that may reflect in an increase of R&D activities and patent applications in this area.
ABERNATHY, W. J., Utterback, J. M. (2004). Patterns of industrial innovation. In: Burgelman et al. (2004). Strategic Management of Technology and Innovation, Mc. Granwhill, p. 202-208.
BARBOSA, D.B. (2003). Uma introdução à propriedade intelectual, 2 a edição, Lumen Juris editora, Rio de Janeiro, 1268p.
BOLDRIN, M., Levine, D.K. (2008). Perfectly competitive innovation. Journal of Monetary Economics, 55, 435-453.
CARVALHO, D.S., Oliveira, L. G., Winter, E., Mothé, C. G. (2009). Technological Foresight Based on Citing ad Cited Patents of Cellulose with Pharmaceutical Applications. Journal of Technology Management & Innovation, 4, 32-41.
CHAVES, G.C., Oliveira, M.A., Hasenclever, L., Melo, L.M. (2007). A evolução do sistema internacional de propriedade intelectual: proteção patentária para o setor farmacêutico e acesso a medicamentos. Cadernos de Saúde Pública, 23, 257-267.
CHRISTENSEN, Grossman, Hwang (2009). The role of disruptive technology and business model innovation in making products and services affordable and accessible (Cap. 1.) and The technological enablers of disruption (Cap. 2), In: The innovator´s prescription, p. 1-72.
COELHO, G. M.. Coelho D. M. S. (2003). Metodologias e Experiências Nacionais e Internacionais, Nota Técnica 14, In: Projeto CTPETRO Tendências Tecnológicas, Instituto Nacional de Tecnologia, Rio de Janeiro, Brasil. http://www.davi.ws/prospeccao_tecnologica.pdf [Accessed March 17, 2010]
FLORÊNCIO, A. P. S., Melo, J. H. L., Mota, C. R. F. C., Melo-Júnior, M. R., Hippel, Von, Eric. (1998). Overview (cap. 1), Users as innovators (cap. 2), Variations in the functional source of innovation (cap. 3) In: The sources of innovation, p.3-42
KLINE, S.J., Rosenberg, N. (1986). An overview of innovation, p. 275-305.
LEONARD-BARTON (1995). A natureza das aptidões e das limitações, cap. 1 (Aptidões estratégicas) e cap. 6 (Importação e absorção de saber tecnológico de fora da empresa), p. 19-46, 163-206.
MALERBA, F. (2003). Sectoral systems and innovation and technology policy. Revista Brasileira de Inovação, 2(2), julho/dezembro, 329-375.
MALERBA, F. (2005). Sectoral systems of innovation, Cap. 14, p. 380-406.
MOREIRA, A.C., Müller, A.C.A., Pereira Jr., N., Antunes, A.M.S. (2006) Pharmaceutical patents on plant derived materials in Brazil: Policy, law and statistics. World Patent Information, 28, p. 34-42.
TIDD, J., BESSANT J., PAVITT K. (1997). Paths: exploiting technological trajectories, (cap. 5). In: Managing Innovation, Wiley, New York, p. 105-132.
UTTERBACK, J. M. (1994). Innovation and Industrial Evolution Mastering the Dynamics of Innovation, cap. 4, 5 and 6, In: Harvard Business School Press, Boston, p. 85-158.
WEST, J., GALLAGNER, S. (2006). Challenges of open innovation: the paradox of firm investment in open-source software. R+D Management, 319-331.
How to Cite